CC
Insider
Christopher R. Cline
CHIEF FINANCIAL OFFICERChristopher R. Cline (CHIEF FINANCIAL OFFICER) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $3.1M of TVTX (50,108 sh across 3 lots, as filed), executed Sep 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.5M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$3.1M50,108 sh across 3 lots
Exec Sep 15
Filed Sep 17 · 9:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $102K
2,181 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $304K
7,239 sh × $41.93
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $233K
7,242 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $700K
20,000 sh × $35.01
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $104K
5,192 sh × $20.12
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET